PT1077728E - Proteccao contra danos por irradiacao ionizante ou droga quimioterapeutica por terapia genetica in vivo - Google Patents

Proteccao contra danos por irradiacao ionizante ou droga quimioterapeutica por terapia genetica in vivo

Info

Publication number
PT1077728E
PT1077728E PT99921357T PT99921357T PT1077728E PT 1077728 E PT1077728 E PT 1077728E PT 99921357 T PT99921357 T PT 99921357T PT 99921357 T PT99921357 T PT 99921357T PT 1077728 E PT1077728 E PT 1077728E
Authority
PT
Portugal
Prior art keywords
subject
vivo
protection against
against damage
genetic therapy
Prior art date
Application number
PT99921357T
Other languages
English (en)
Inventor
Joel S Greenberger
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Publication of PT1077728E publication Critical patent/PT1077728E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT99921357T 1998-05-11 1999-05-07 Proteccao contra danos por irradiacao ionizante ou droga quimioterapeutica por terapia genetica in vivo PT1077728E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/075,532 US6221848B1 (en) 1998-05-11 1998-05-11 Protection of the esophagus from chemotherapeutic or irradiation damage by gene therapy

Publications (1)

Publication Number Publication Date
PT1077728E true PT1077728E (pt) 2006-05-31

Family

ID=22126381

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99921357T PT1077728E (pt) 1998-05-11 1999-05-07 Proteccao contra danos por irradiacao ionizante ou droga quimioterapeutica por terapia genetica in vivo

Country Status (10)

Country Link
US (1) US6221848B1 (pt)
EP (1) EP1077728B1 (pt)
JP (1) JP2002514608A (pt)
AT (1) ATE314864T1 (pt)
AU (1) AU769805B2 (pt)
CA (1) CA2331569A1 (pt)
DE (1) DE69929327T2 (pt)
ES (1) ES2257049T3 (pt)
PT (1) PT1077728E (pt)
WO (1) WO1999058154A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887856B1 (en) * 1993-10-15 2005-05-03 University Of Pittsburgh Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy
WO2009158563A1 (en) * 2008-06-26 2009-12-30 Spectrum Health Method for treating or preventing radiation damage by in vivo gene therapy
US20110225661A1 (en) * 2008-06-26 2011-09-15 Spectrum Health Innovations, LLC Method for treating and preventing radiation damage using genetically modified mesenchymal stem cells
WO2012068081A1 (en) * 2010-11-15 2012-05-24 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Intraesophageal administration of targeted nitroxide agents for protection against ionizing irradiation-induced esophagatis
US20240261375A1 (en) * 2021-05-18 2024-08-08 Ltt Bio-Pharma Co., Ltd. Pharmaceutical composition for treating or preventing disorder associated with administration of anticancer agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980286A (en) 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
EP0676472A1 (de) 1987-03-14 1995-10-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Humane Mangan-Superoxiddismutase (hMn-SOD)
US5858784A (en) 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US5843641A (en) * 1993-02-26 1998-12-01 Massachusetts Institute Of Technology Methods for the daignosis, of familial amyotrophic lateral sclerosis
IL109112A0 (en) 1993-03-24 1994-06-24 Boehringer Ingelheim Pharma Pharmaceutical compositions containing human manganese superoxide dismutase
US5599712A (en) * 1993-10-15 1997-02-04 University Of Pittsburgh Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy
WO1998000160A1 (en) * 1996-06-28 1998-01-08 Nat Jewish Ct Immun & Respirat USE OF THIOREDOXIN-LIKE MOLECULES FOR INDUCTION OF MnSOD TO TREAT OXIDATIVE DAMAGE

Also Published As

Publication number Publication date
EP1077728A1 (en) 2001-02-28
DE69929327D1 (de) 2006-03-30
ATE314864T1 (de) 2006-02-15
AU769805B2 (en) 2004-02-05
EP1077728B1 (en) 2006-01-04
WO1999058154A1 (en) 1999-11-18
JP2002514608A (ja) 2002-05-21
DE69929327T2 (de) 2006-09-07
US6221848B1 (en) 2001-04-24
CA2331569A1 (en) 1999-11-18
ES2257049T3 (es) 2006-07-16
AU3859399A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
HK1078771A1 (en) Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiationin the treatment of cancer
HK1084032A1 (en) Combination therapy of zd6474 with 5-fu and/or cpt-11
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
TW200518752A (en) Combinations of drugs for the treatment of neoplasms
BRPI0412426A (pt) uso da zd6474 ou de um sal farmaceuticamente aceitável da mesma e de um agente antitumoral de platina, composição farmacêutica, kit, e método para a produção de um efeito antiangiogênico e/ou redutor de permeabilidade vascular em um animal de sangue quente
MX2007003506A (es) Terapia de combinacion de cancer que comprende azd2171 e imatinib.
WO2006035204A3 (en) Combination comprising zd6474 and an imatinib
IL191796A0 (en) Combination of zd6474 and pemetrexed
BR0213906A (pt) Métodos para a produção de um efeito anti-angiogênico e ou redutor da permeabilidade vascular em um animal de sangue quente, e para o tratamento de um câncer em um animal de sangue quente, composição farmacêutica, kit, e, uso de zd6474 ou um seu sal farmaceuticamente aceitável e um taxano
MX2007005356A (es) Terapia de combinacion que comprende zd6474 y un antiadrogenico.
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
NO20082566L (no) Kombinasjon av AZ2171 og permetrexed
MX2023006205A (es) Tratamiento y diagnostico fotodinamico.
NO20064755L (no) Kombinasjonsterapi
PT1077728E (pt) Proteccao contra danos por irradiacao ionizante ou droga quimioterapeutica por terapia genetica in vivo
NO20056171L (no) Kombinasjonsterapi
NO20064753L (no) Kombinasjonsterapi
WO2007003933A3 (en) Combination therapy of cancer with azd2171 and gemcitabine
GR3031418T3 (en) Benzazole compounds for use in therapy
WO2005092385A3 (en) Combination therapy of azd2171 and a taxane
MX2020013883A (es) Tratamientos oncológicos con agentes de zinc.
MXPA05013827A (es) Composiciones que comprenden zd6126 junto con 5-fu, cpt-11 o 5-fu y cpt-11, que tienen actividad de dano vascular, para tratar cancer colorectal e. g.
EP4384278A4 (en) ANTI-METASTATIC AGENT EFFECTIVE ON PROSTATE CANCER CELLS AND SUITABLE FOR USE IN THE TREATMENT OF THESE DISEASES
WO2024026400A3 (en) Therapeutic combinations of titr effectors with radiation therapy
MX2024006481A (es) Terapia fotodinámica y diagnóstico.